dr benjamin garfield brompton hospital

Study A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial, Study contact information Assessment of the WATCHMAN device in patients unsuitable for oral anticoagulation, Study contact information SPACE FOR COPD delivered as a maintenance programme on Pulmonary Rehabilitation discharge: a randomised controlled trial evaluating the long-term effects on exercise tolerance and mental well-being, Study contact information Study contact information Digital tools in Heart failure a survey of patient usage, Study contact information Study Actor, Andrew Garfield shares a very special message of support for Royal Brompton Hospital and our Crisis Care Appeal - https://www.justgiving.com/campaign/. Name:Angela GallagherEmail:a.gallagher2@rbht.nhs.uk, Principal investigator Study Utility of cardiopulmonary exercise testing and stress echocardiography in the assessment of breathlessness following pulmonary embolism: a pilot study, Study Effectiveness of intravenous iron treatment vs standard care in patients with heart failure and iron deficiency: a randomised, open-label multicentre trial (IRONMAN), Study Dr Ciara Bucciarelli-Ducchi, Study Name:Cheyanne KaillaEmail:c.kailla@rbht.nhs.uk, Principal investigator Name: Dr Mark MasonEmail: M.Mason@rbht.nhs.uk, Study Study A Surgical Site Infection Risk Prediction Tool to Enable Targeted Infection Prevention Strategies in Adult Cardiac Surgery. Professor Sejal Saglani. Name:Najwa SoussiEmail:N.Soussi@rbht.nhs.uk, Principal investigator Study Name:Dr Justin GarnerEmail:J.Garner@rbht.nhs.uk, Study Name:Paula RogersEmail: p.rogers@rbht.nhs.uk, Study Acute muscle wasting in critical illness an observational cohort study. VIVO experience in a practical clinical setting. Assessment of the Safety and Performance of the AB1 Electrosurgical System for Bronchoscopic Microwave Ablation of Lung Tissue, Study contact information Name:Sarah CollinsEmail:s.collins@rbht.nhs.uk, Study A Phase 2, Multi-Centre, Open-Label, Single-Arm Trial Investigating the Safety, Efficacy and Pharmacokinetics of C21 in Subjects with Idiopathic Pulmonary Fibrosis, Study contact informationName: Victor JardimEmail: V.Jardim@rbht.nhs.uk, Study An observational study of neurodevelopmental outcome after cardiac arrest in children admitted to paediatric intensive care, Study contact information Study FFRCT In Stable Heart disease & CTA Helps Improve Patient care and Societal costs, Study contact information Study contact informationName:Lyn PaulEmail:l.paul@rbht.nhs.uk. The Clinical and psychosocial impact of COVID-19 on patients with neuromuscular and neurological disorders, Study contact information Ms Lynda Shaughnessy, Study Study contact information Name:Richard MordiEmail:R.Mordi@rbht.nhs.uk, Study WHO ISARIC Clinical Characterisation Protocol for Severe Emerging Infection UK (CCP-UK) / Novel Coronavirus Observational Study, Study contact information Name:Huw EllisEmail:Huw.Ellis@rbht.nhs.uk, Study Dr Julene Carvalho, Study Study contact information Nasal Allergen Challenge: standardisation as a surrogate for hay fever, Principal investigator A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH, Study contact informationName: Joy PinguelEmail: a.pinguel@rbht.nhs.uk, Study Study contact information TrIFIC: Targeting Immunotherapy for Fungal Infection in Cystic Fibrosis, Study contact information Digital tools in Heart failure patient and clinician perspectives, Study contact information Video assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a multi-centre randomised controlled trial with an internal pilot, Study Name: Dr Ali VazirEmail: a.vazir@rbht.nhs.uk, Study A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease, Study Study The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): a randomised placebo-controlled multi-centre clinical trial, Study Name: Camilla GoulsbraEmail: c.goulsbra@rbht.nhs.uk, Study Dr. Benjamin C. Tam, MD | Pacific Orthopedic, Alahambra, CA - Zocdoc Reverse rEmodelling Markers In the serial evaluation of recenTonset Dilated CardioMyopathy, Study contact informationName: Dr Daniel HammersleyEmail:d.hammersley@rbht.nhs.uk, Study Name: Kartik KumarEmail: K.Kumar2@rbht.nhs.uk, Study Name:Dr Sandra Gala-PeraltaEmail:s.gala-peralta@rbht.nhs.uk, Principal investigator Name:Lydia SpurrEmail:l.spurr@rbht.nhs.uk, Study Name: Dr Carole RidgeEmail:C.Ridge@rbht.nhs.uk, Study Royal Brompton & Harefield Hospitals Specialist Care | London - Facebook CYtosorb modulation of surgiCal infLammatiON during LVAD insErtion (CYCLONE-LVAD) study, Study contact informationName:Louise MossEmail:L.McBrearty@rbht.nhs.uk, Study Name:Natalie DormandEmail:N.Dormand@rbht.nhs.uk, Study A Phase 3 Open-label Study Evaluating the Longterm Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 2 Years and Older, Study contact information Heterotaxy and abnormalities in intestinal rotation, Study contact information Measurement of novel indices of lung function in respiratory disease, Study contact information A phase 2, double-blind, randomised, placebo-controlled, two-treatment, two-period crossover efficacy and safety study in Idiopathic Pulmonary Fibrosis (IPF)with Nalbuphine ER tablets for the treatment of cough. Study Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF). Name: Peter JungEmail: p.jung@rbht.nhs.uk, Study Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes, Study contact information An open-label study to assess the safety, pharmacokinetics and pharmacodynamics of inhaled PC945 in adult Cystic Fibrosis (CF) patients with persistent pulmonary Aspergillus fumigatus infection, Study contact information Name: Clare SaundersEmail:C.Saunders2@rbht.nhs.uk. Dr Stephen John Wort, Study Name:Debra Dempster (Royal Brompton), Claire Prendergast(Harefield)Email:D.Dempster@rbht.nhs.uk,C.Prendergast2@rbht.nhs.uk, Study This study aims to provide a contemporary, population-level assessment of the true clinical burden of myocarditis and how this may have changed over the last 20 years. Having more than 5 years of diverse experiences, especially in NURSE PRACTITIONER, Dr. Benjamin Garfield Rae affiliates with no hospital, cooperates with many other doctors and specialists in medical group Ideal Option Pllc. Name: Michelle RackhamEmail: M.Rackham@rbht.nhs.uk, Study Study Study Study A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes), Study A Phase 3, 2-Arm, open-label study to evaluate the safety and pharmacodynamics of long-term Ivacaftor treatment in subjects with Cystic Fibrosis who are less than 24 Months of age at treatment initiation and have a CFTR gating mutation, Study contact information Dr Mario Petrou & Dr Sunil Bhudia, Study Dr. Benjamin Tam, MD, Orthopedic Surgery | Alhambra, CA | WebMD We provide private. National cohort study of Idiopathic and Heritable Pulmonary Arterial Hypertension, Study contact information Professor Dudley Pennell. Benjamin E. Garfield | MediFind Name: Selvy RajuEmail: S.Raju@rbht.nhs.uk, Study COVID-19 antibody responses in Cystic Fibrosis patients, Study contact information Study Search for this keyword . Name: Nicky MurrayEmail:N.Murray@rbht.nhs.uk, Study Dr Nicholas Hopkinson, Study Name:Katherine RhatiganEmail:K.Rhatigan@rbht.nhs.uk, Study The Effects of inorganic nitrite on cardiac and skeletal muscle: Physiology, pharmacology, and therapeutic potential in patients with Chronic Heart Failure, Study contact information dr benjamin garfield brompton hospital. Dr Matthew O'Connor. Royal Brompton and Harefield hospitals are home to seven purpose-built catheter laboratories, where each year our consultants carry out over 400 coronary angioplasties (stenting) to help widen arteries. Study Fingerprinting proteoglycan turnover by ADAMTS proteases in the cardiovasculature, Study contact information Name:Gavin DonaldsonEmail:gavin.donaldson@imperial.ac.uk, Study Name:Debra DempsterEmail:D.Dempster@rbht.nhs.uk, Study A prospective cross-sectional study analysing the utility of novel tablet-based audiometry and an interactive web-based hearing app as screening tools for drug-induced ototoxicity in adults with cystic fibrosis. PAciFy Cough: A multicentre, double blind, placebo controlled, crossover trial of morphine sulfate for the treatment of PulmonAry Fibrosis Cough, Study contact informationName:Zhe WuEmail:Z.Wu@rbht.nhs.uk. UK lung volume reduction - multicentre observational, Study contact information Name:Dr Stephen John WortEmail:s.wort@rbht.nhs.uk, Principal investigator Can thrombosis and fibrinolysis markers in patients undergoing aortic valve replacement predict outcome, Study contact information NEURO-PACK: Neurologic prognosis after cardiac arrest in kids. Name: Victoria DoughtyEmail: v.doughty@rbht.nhs.uk, Principal investigator A RandomisEd ControlLed Study of PnEumRx Endobronchial Coil System Versus Standard-of-Care Medical MAnagement in the Treatment of Subjects with Severe Emphysema (ELEVATE) A Postmarket Surveillance Study (PMS). Defining the genetics, biomarkers and outcomes for dilated cardiomyopathy: a prospective multi-centre observational study, Study contact informationName: Teijo PalovaaraEmail:T.Palovaara@rbht.nhs.uk, Study Study Professor Michael Polkey, Study Study Dr Isabela Skypala, Study Name: Sally MeahEmail: S.Meah@rbht.nhs.uk, Study contact information A Phase 3 study of the long-term safety of a triple combination therapy of VX-445, tezacaftor and ivacaftor in people with cystic fibrosis aged 12 and older. Name: David SmithEmail: d.smith22@rbht.nhs.uk, Study Name:Avantika TailorEmail:A.Tailor@rbht.nhs.uk, Study Deep learning for HRCT classification of fibrotic lung disease, Study Name: Antonio BarberaEmail: a.barbera@rbht.nhs.uk, Study Utility of Emphasis-10 in Risk Stratification in Pulmonary Arterial Hypertension. A Pan-European Multi-Centre Observational Study To Determine The Natural History Of Patients With Alpha-1 Antitrypsin Deficiency And The Impact Of Augmentation Therapy, Study contact information Name:Gemma StanfordEmail:G.Stanford@rbht.nhs.uk, Principal investigator Name:Dexter WisemanEmail:D.Wiseman@rbht.nhs.uk, Principal investigator A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib, 150 mg twice daily for 52 weeks (with follow up until last patient out up to a maximum of 2 years) in patients with systemic sclerosis associated interstitial lung disease, Study contact information Name:Yousuf SalmasiEmail:M.Salmasi@rbht.nhs.uk, Principal investigator What are common reasons for patients to see Dr. Benjamin C. Tam? Characterising the Mechanism of Action of Metered Cryospray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease with Chronic Bronchitis, Study contact information Royal Brompton Hospital is a regional centre for pulmonary hypertension in the UK. A Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled, 52-Week, Phase III Study With an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab in Patients With Non-Cystic Fibrosis Bronchiectasis With Eosinophilic, Study contact information Prospective cohort study of haemostatic activation markers and correlation with bleeding and thrombotic complications in patients receiving extracorporeal membrane oxygenation(ECMO), Study contact information Homepage | Royal Brompton & Harefield hospitals A cross sectional feasibility study examining the relationship between peak cough flow and respiratory function testing (spirometry) post bilateral sequential single lung transplantation, at a single centre cardiothoracic transplantation unit, Study contact information Study contact information Study contact informationName: Professor Athol WellsEmail: RBHILD@rbht.nhs.uk, Principal investigator Study Development of Cardiovascular Magnetic Resonance (CMR) sequences for future clinical use, Study contact information Study Study contact information Many experts have expertise treating . Study Multicentre, open-label, active-controlled, randomised study to evaluate the efficacy and safety of an age and body weight-adjusted rivaroxaban regimen in children with acute venous thromboembolism, Study contact information Study Metatranscriptomics in Non-Tuberculous Mycobacterial Pulmonary Disease, Study contact information Study contact informationName: Jovile KazileviciuteEmail: j.kazileviciute@rbht.nhs.uk, Study Name:Ms Rebecca LaneEmail:r.lane@rbht.nhs.uk, Study Name:DeepaArachchillageEmail:D.JayakodyArachchillage@rbht.nhs.uk, Principal investigator Impact of smoking cessation on skeletal muscle atrophy and hypertrophy pathways in COPD, Study contact information The EMBARC European Bronchiectasis Registry, Study Cardiology | Royal Brompton & Harefield Hospitals Specialist Care Name:Merriel WoodruffEmail:M.Woodruff@rbht.nhs.uk, Study A Phase 3, multinational, randomised, placebo-controlled study of ARRY-371797 in patients with Symptomatic Dilated Cardiomyopathy due to a Lamin A/C Gene Mutation, Study contact informationName: Dr James WareEmail: J.Ware@rbht.nhs.uk, Study contact information A double-blind, placebo controlled, multicentre, clinical trial to investigate the efficacy and safety of 12 months of therapy with inhaled Promixin (colistimethate sodium) in the treatment of subjects with non-cystic fibrosis bronchiectasis, Study Use of MRI in the assessment of cystic fibrosis and primary ciliary dyskinesia - A clinical feasibility study, Study contact information A Multicenter, Cross-sectional Study to Characterize the Distribution of Lipoprotein(a)Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD), Study contact information A case-referent study of the exposure history of adults with hypersensitivity pneumonitis, Study contact information A single-centre, placebo-controlled, double-blinded, randomised, crossover study of Iloprost (Ventavis) in patients with Eisenmenger syndrome, Study contact information Single-centre validation of finger-prick capillary blood sampling for remote monitoring in chronic lung disease including antifungal therapeutic drug monitoring. Safe and Timely Antithrombotic Removal (STAR REGISTRY): International registry on the use of CytoSorb for removal of antithrombotic agents in the acute hospital setting. Name:Laura GardnerEmail:L.Gardner@rbht.nhs.uk, Study Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: the COVID-HEART study, Study contact information Comparative STudy chaRacterising the physiological changEs induced by Surgical and tranScatheter Mitral Regurgitation reduction - STRESS-MR, Study contact information Name: Dr Haseeb ValliEmail: h.valli@rbht.nhs.uk, Study Lobar Segmented Iodine Mapping of the Lungs using Dual Energy Computed Tomography in Advanced Chronic Obstructive Pulmonary Disease. A prospective, multicentre, randomised, blinded study of obstructive sleep apnoea detection using the Sunrise solution: The Sunrise OSA Trial (SOSAT), Study contact information Real-world experience of dupilumab for the treatment of severe asthma in the United Kingdom: a retrospective study. Study Name: Mr Philip MolyneauxEmail: p.molyneaux@rbht.nhs.uk, Principal investigator Study An open-label randomised, parallel-group, multicenter, observational trial to evaluate the safety and efficacy of edoxaban tosylate in children from 38 weeks gestational age to less than 18 years of age with cardiac disease at risk of thromboembolic events. Name:Mahitha GummadiEmail:M.Gummadi@rbht.nhs.uk, Study Study Name:Professor Michael LoebingerEmail:M.Loebinger@rbht.nhs.uk. Study contact informationName: Natalie DormandEmail:N.Dormand@rbht.nhs.uk, Study Name:Dr Melissa SanchezEmail:M.Sanchez@rbht.nhs.uk, Principal investigator Embolization coil systems: RETRACTA and HILAL, Study contact informationName: Dr Carole RidgeEmail: c.ridge@rbht.nhs.uk. Cardiac complicAtions in Patients with SARS Corona vIrus 2 regisTrY (CAPACITY), Study contact information Name: Yvonne BinghamEmail: y.bingham@rbht.nhs.uk, Study Outcome validation in noses of subjects with cystic fibrosis and non-CF volunteers, Study contact information Study Name: Dr Brian HallidayEmail: B.Halliday@rbht.nhs.uk, Study Name:Dr Anand DevarajEmail:a.devaraj@rbht.nhs.uk, Study Hpitaux in Saint-Marcellin, Auvergne-Rhne-Alpes . Genetic determinants of Kawasaki disease for susceptibility and outcome, Study contact information Coagulation markers on discarded plasma samples from patients with severe COVID-19, Study contact information Study contact informationName: Mr Zain OdhoEmail: Z.Odho@rbht.nhs.uk. Professor Anand Devaraj, Study Study Minimally invasive thoracoscopically-guided right minithoracotomy versus conventional sternotomy for mitral valve repair: a multicentre randomised controlled trial (UK Mini Mitral), Study contact information Name:Carmen ChanEmail:L.Chan2@rbht.nhs.uk, Study Name: Dr Anand ShahEmail:A.Shah2@rbht.nhs.uk, Study Improving Assessment of Diagnosis and Prognosis in Cardiac Sarcoidosis, Study contact informationName:Dr Alessia AzzuEmail:A.Azzu@rbht.nhs.uk, Study Name:Professor Sanjay PrasadEmail:S.Prasad@rbht.nhs.uk, Principal investigator Adherence to inhaled corticosteroids in young people with problematic severe asthma, Study contact information Open-Label, Baseline-Controlled, Two-Period, Exploratory Study of Safety, Tolerability and Pharmacodynamics of Oral MYK-491 in Stable Ambulatory Patients with Primary Dilated Cardiomyopathy Associated with MYH7 Mutation, Study contact information Study contact information Dr Nicoletta Zimbler, Study National Validation and Sensitivity to Change of a scale to measure quality of life in patients with severe asthma. Does Extra-Corporeal Membrane Oxygenation alter anti-infectives therapy pharmacokinetics in adult critically ill patients? Non-invasive detection of Pseudomonas aeruginosa lower airway infection in patients with Cystic Fibrosis, Study contact information 58 Boulevard Becquart Castelbon, Voiron, Auvergne-Rhne-Alpes 38500 +33 4 76 65 03 39 . Targets of bronchial thermoplasty in severe asthma, Study contact information Name:Bhavin RawalEmail:B.Rawal@rbht.nhs.uk, Principal investigator Dr Nicholas Simmonds. dr benjamin garfield brompton hospital - eventup.live Name:Brian HallidayEmail:B.Halliday@rbht.nhs.uk, Study Dr Andres Rico-Armada, Study Professor Jane Davies. EON-Lung: Nitrate levels in Lung Disease - an observational study, Study contact information Dr Julene S Carvalho, Study Ben Garfield's research works | Royal Brompton and Harefield NHS Severe wheeze and asthma validation study, Study contact information The DEPICT study, Study contact information Name: Rosemarie BollaEmail: r.bolla@rbht.nhs.uk, Study Name: Nikula VicarioEmail: n.vicario@rbht.nhs.uk, Study

John Burroughs High School, Burbank Memorial Page, Articles D